Central nervous system (CNS) involvement is rare but it is an increasingly recognized complication of the multiple myeloma. The craniospinal radiotherapy is a standard treatment option, however, it may be challenging to deliver due to hematologic toxicity in the patients with multiple prior systemic therapies. We report a case of CNS myelomatosis in a patient with prior stem cell transplant multiple systemic therapies treated with bone marrow-sparing proton therapy craniospinal irradiation, with the dramatic clinical response and minimal hematologic toxicity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786350 | PMC |
| http://dx.doi.org/10.7759/cureus.1885 | DOI Listing |
Publication Analysis
Top Keywords
bone marrow-sparing
8
marrow-sparing proton
8
proton therapy
8
therapy craniospinal
8
craniospinal irradiation
8
central nervous
8
nervous system
8
hematologic toxicity
8
systemic therapies
8
case report
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!